Michael Zaleski

Michael Zaleski practices at UPMC Horizon - Greenville in Greenville, Pennsylvania, part of University of Pittsburgh Medical Center.

Michael Zaleski's NPI, 1730769787, was assigned on April 13, 2021. Michael Zaleski holds Pennsylvania license MD484270.

Michael Zaleski's primary practice is UPMC Horizon - Greenville, at 110 North Main Street, Greenville, PA 16125 in Mercer County. The practice phone is (724) 588-2100.

Michael Zaleski's primary practice is UPMC Horizon - Greenville in Greenville, Pennsylvania, part of University of Pittsburgh Medical Center. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Michael Zaleski to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Zaleski practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Michael Zaleski's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Michael Zaleski is licensed in Pennsylvania.

CMS data shows 195 Medicare services from Michael Zaleski across 3 procedure codes in 2024, for 139 Medicare patients. Medicare paid $15,782 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 139 Medicare patients who saw Michael Zaleski in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Zaleski's median patient age at 72, with 55% women.

In 2024, Michael Zaleski wrote 142 Medicare Part D claims for 107 patients. 97% of them were for generic drugs. CMS names the drug for 51 of them, across 3 drugs with 11 or more claims each, at $377 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Michael Zaleski for performance year 2024, reported as part of a group.

Dmand AI links 21 papers to Michael Zaleski, published from 2018 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Nanoparticles, Biomarkers, Tumor and Complement Activation. Michael Zaleski has published most often in Adv Mater. Michael Zaleski's most frequent co-authors are Jacob Samuel Brenner, MD, PhD, Michael Phillip Zaleski, DO and Cesar A. Moran, MD.